do glp 1 drugs cause cancer GLP-1s Lower Risk? Do GLP-1 drugs cause cancer?

Administration timing may affect blood sugar control and overall tolerance

In clinical trials, patients using injectable semaglutide lost an average of 15% to 16% of their body weight over 64 weeks, while those using an oral semaglutide formulation lost approximately 13%. The difference is meaningful but modest, and for many people the convenience and lower friction of an oral format may more than offset a slightly lower average weight loss

"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis"

Verdich, C

Platelet-Rich Plasma, Shockwave Therapy Show Therapeutic Efficacy in Interstitial Cystitis FRIDAY, July 31, 2026 -- For patients with interstitial cystitis (IC)/bladder pain syndrome (BPS), the combination of platelet-rich plasma (PRP) and low-intensity extracorporeal

Here, we identify TRIM37, a member of the TRIM E3 ubiquitin ligase family, 16 as indispensable for maintaining PGC identity during migration